ABT-CIP-10458
Showing 26 - 50 of 431
Establishment of Predictive Models of Checkpoint Inhibitor
Not yet recruiting
- Pneumonia, Interstitial
- Immune checkpoint inhibitors(ICIs) therapy
- (no location specified)
Aug 19, 2021
XIENCE Skypoint Large Vessel Post Approval Study
Not yet recruiting
- Coronary Artery Disease
- XIENCE Skypoint Large Vessel Everolimus Eluting Coronary Stent System (EECSS)
- (no location specified)
Jun 15, 2022
Secondary Sclerosing Cholangitis Trial (Endoscopic retrograde cholangiography (ERC))
Not yet recruiting
- Secondary Sclerosing Cholangitis
- Endoscopic retrograde cholangiography (ERC)
- (no location specified)
May 25, 2022
LBBAP Data Collection Registry
Recruiting
- Bradycardia
- +5 more
- Implantation of the Tendril 2088 lead in the LBBA
-
Gurgaon, Nct Dlh, IndiaMedanta - The Medicity Hospital
Jun 1, 2023
HIV, Tuberculosis Trial in Dire Dawa, Harar (Combination intervention components, Isoniazid Prevention Therapy)
Completed
- HIV
- Tuberculosis
- Combination intervention components
- Isoniazid Prevention Therapy
-
Dire Dawa, Ethiopia
- +9 more
Jul 12, 2021
Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)
Active, not recruiting
- Chronic Lymphoid Leukemia
- Bendamustine
- +3 more
-
Dresden, Germany
- +16 more
Nov 8, 2022
Regent China Post-Market Clinical Follow-up Study
Recruiting
- Valvular Heart Disease
- Aortic Valve Disease
- Abbott Mechanical Heart Valve (MHV) Regentâ„¢
-
Gaozhou, China
- +5 more
Jan 30, 2023
Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)
Recruiting
- Hidradenitis Suppurativa
- Lutikizumab
- Placebo
-
Phoenix, Arizona
- +54 more
Jan 26, 2023
Amuletâ„¢ ADVANCE LAA
Recruiting
- Atrial Fibrillation
- +2 more
- Left atrial appendage occlusion (LAAO)
-
Phoenix, Arizona
- +5 more
Aug 15, 2023
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))
Not yet recruiting
- Endometriosis
- Moderate to Severe Endometriosis-associated Pain
- BG2109 100mg
- +5 more
- (no location specified)
Jun 6, 2023
Aveir DR Real-World Evidence Post-Approval Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir DR Leadless Pacemaker System
-
Sylmar, CaliforniaAbbott
Jul 5, 2023
Tuberculosis, HIV Trial in Lesotho (Combination Intervention Package, Standard of Care)
Completed
- Tuberculosis
- HIV
- Combination Intervention Package
- Standard of Care
-
Koali, Lesotho
- +11 more
Jul 12, 2021
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021
Aveir AR Coverage With Evidence Development (CED) Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir AR Leadless Pacemaker
- Single-chamber atrial transvenous pacemaker
- (no location specified)
Oct 30, 2023
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021
Chronic Idiopathic Urticaria, Chronic Idiopathic Pruritus, Lichen Planus Trial in United States (KPL-716, Placebo)
Completed
- Chronic Idiopathic Urticaria
- +4 more
- KPL-716
- Placebo
-
Anniston, Alabama
- +18 more
Nov 29, 2021
Pattern for Cannabis-induced Psychosis
Completed
- Cannabis
- cannabis
-
Thanyaburi, Pathum Thani, ThailandOnrumpha Chuenchom
Jun 21, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 8, 2021
Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell Trial in United States (ABT-199 and Ibrutinib Combination)
Completed
- Lymphoma, Mantle-Cell
- Recurrent Lymphoma, Mantle-Cell
- ABT-199 and Ibrutinib Combination
-
Duarte, California
- +3 more
May 22, 2022
Chronic Intractable Pain Trial in Canada, United Kingdom (BurstDR-SCS)
Terminated
- Chronic Intractable Pain
- BurstDR-SCS
-
Toronto, Canada
- +4 more
Sep 5, 2023
AVEIR DR Coverage With Evidence Development (CED) Study
Not yet recruiting
- Cardiac Pacemaker
- +2 more
- Aveir DR Leadless Pacemaker System
- Dual Chamber Transvenous Pacemaker
- (no location specified)
Jul 5, 2023
Sport-related Concussion Trial in Plano (Screen Time Restriction (ST-Restricted), Aerobic Exercise (AE), Screen-time restricted
Recruiting
- Sport-related Concussion
- Screen Time Restriction (ST-Restricted)
- +3 more
-
Plano, TexasChildren's Health - Andrews Institute
Aug 22, 2022